MARSHALL WACE, LLP - PROCEPT BIOROBOTICS CORP ownership

PROCEPT BIOROBOTICS CORP's ticker is and the CUSIP is 74276L105. A total of 115 filers reported holding PROCEPT BIOROBOTICS CORP in Q1 2023. The put-call ratio across all filers is 4.11 and the average weighting 0.4%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of PROCEPT BIOROBOTICS CORP
ValueSharesWeighting
Q2 2023$604,485
+15.7%
17,100
+35.9%
0.00%0.0%
Q4 2022$522,531
-78.1%
12,579
-78.2%
0.00%
-80.0%
Q3 2022$2,388,000
+662.9%
57,580
+503.4%
0.01%
+400.0%
Q2 2022$313,000
-89.3%
9,543
-91.8%
0.00%
-80.0%
Q4 2021$2,914,000116,4930.01%
Other shareholders
PROCEPT BIOROBOTICS CORP shareholders Q1 2023
NameSharesValueWeighting ↓
CPMG Inc 5,328,867$174,840,12695.60%
JOHNSON & JOHNSON 357,939$11,743,9794.33%
Frank, Rimerman Advisors LLC 456,953$14,992,6283.63%
Eagle Health Investments LP 337,218$11,064,1232.44%
Taylor Frigon Capital Management LLC 124,462$4,083,5982.27%
Evolutionary Tree Capital Management, LLC 49,060$1,609,6592.08%
Rhenman & Partners Asset Management AB 493,000$16,175,3301.74%
AtonRa Partners 16,462$540,1181.13%
Point72 Europe (London) LLP 406,271$13,329,7520.82%
SANDLER CAPITAL MANAGEMENT 211,200$6,929,4720.71%
View complete list of PROCEPT BIOROBOTICS CORP shareholders